| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |